Innovive Pharmaceuticals, Inc. (IVPH.OB) is a publicly traded company in the Unknown sector. Across all available filings, 6 corporate insiders have executed 10 transactions totaling $50.0K, demonstrating a bullish sentiment with $50.0K in net insider flow. The most recent transaction on Sep 19, 2008 involved a transaction of 52,127 shares valued at $0.
No significant insider buying has been recorded for IVPH.OB in the recent period.
No significant insider selling has been recorded for IVPH.OB in the recent period.
Based on recent SEC filings, insider sentiment for IVPH.OB is bullish with an Insider Alignment Score of 100/100 and a net flow of $50.0K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Innovive Pharmaceuticals, Inc. (IVPH.OB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 6 insiders are actively trading IVPH.OB stock, having executed 10 transactions in the past 90 days. The most active insider is Adam R. Craig (Executive), who has made 1 transactions totaling $67.8K.
Get notified when executives and directors at IVPH.OB file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Sep 19, 2008 | Herskowitz Neil | Executive | Disposition | 52,127 | $N/A | $0 | |
| Sep 19, 2008 | E. Poma Eric | Executive | Disposition | 63,160 | $N/A | $0 | |
| Sep 19, 2008 | Decaro Angelo | Executive | Disposition | 20,000 | $N/A | $0 | |
| Sep 19, 2008 | Kelly Steven | Executive | Disposition | 158,000 | $N/A | $0 | |
| Sep 19, 2008 | Jay Lobell J. | Executive | Disposition | 162,670 | $N/A | $0 | |
| Apr 24, 2007 | Herskowitz Neil | Executive | Purchase | 18,315 | $2.73 | $50.0K | |
| Aug 10, 2006 | Jay Lobell J. | Executive | Conversion | 25,252 | $N/A | $0 | |
| Aug 10, 2006 | R. Craig Adam | Executive | Conversion | 17,120 | $3.96 | $67.8K | |
| Aug 10, 2006 | Herskowitz Neil | Executive | Conversion | 8,560 | $N/A | $0 | |
| Aug 10, 2006 | Herskowitz Neil | Executive | Conversion | 25,252 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Conversion(C) | 4 | $67.8K | 57.6% |
Purchase(P) | 1 | $50.0K | 42.4% |
Disposition(D) | 5 | $0 | 0.0% |
Insiders at Innovive Pharmaceuticals, Inc. are accumulating shares at an accelerated pace. With 6 insiders making 10 transactions totaling $50.0K in purchases versus $0 in sales, the net buying activity of $50.0K signals strong executive confidence. Adam R. Craig (Executive) leads the buying activity with $67.8K in transactions across all time.